BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,855 | -42.0% | 1,427 | -30.0% | 0.00% | -33.3% |
| Q2 2023 | $92,897 | -7.0% | 2,039 | -17.2% | 0.01% | -14.3% |
| Q1 2023 | $99,940 | +0.9% | 2,464 | +26.7% | 0.01% | 0.0% |
| Q4 2022 | $99,086 | -4.7% | 1,944 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $104,000 | -19.4% | 1,944 | -2.5% | 0.01% | -20.0% |
| Q2 2022 | $129,000 | -25.0% | 1,994 | 0.0% | 0.01% | -9.1% |
| Q4 2021 | $172,000 | -2.3% | 1,994 | -8.8% | 0.01% | -8.3% |
| Q2 2021 | $176,000 | -5.9% | 2,187 | -1.5% | 0.01% | -14.3% |
| Q1 2021 | $187,000 | -4.1% | 2,221 | -8.7% | 0.01% | -12.5% |
| Q4 2020 | $195,000 | +3.2% | 2,433 | +3.4% | 0.02% | -5.9% |
| Q3 2020 | $189,000 | -21.6% | 2,353 | -16.1% | 0.02% | -29.2% |
| Q2 2020 | $241,000 | -4.4% | 2,804 | -9.6% | 0.02% | 0.0% |
| Q1 2020 | $252,000 | -0.4% | 3,101 | +2.6% | 0.02% | +26.3% |
| Q4 2019 | $253,000 | -13.9% | 3,023 | -10.1% | 0.02% | -20.8% |
| Q3 2019 | $294,000 | +10.1% | 3,363 | +3.1% | 0.02% | +9.1% |
| Q2 2019 | $267,000 | +0.8% | 3,263 | 0.0% | 0.02% | -4.3% |
| Q1 2019 | $265,000 | +20.5% | 3,263 | -2.2% | 0.02% | +9.5% |
| Q4 2018 | $220,000 | -19.7% | 3,338 | -6.2% | 0.02% | -8.7% |
| Q3 2018 | $274,000 | +4.6% | 3,558 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $262,000 | +27.2% | 3,558 | +12.5% | 0.02% | +21.1% |
| Q1 2018 | $206,000 | -1.9% | 3,164 | -2.3% | 0.02% | 0.0% |
| Q4 2017 | $210,000 | -4.1% | 3,239 | -7.2% | 0.02% | -13.6% |
| Q3 2017 | $219,000 | +3.8% | 3,489 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $211,000 | +24.1% | 3,489 | +6.3% | 0.02% | +22.2% |
| Q1 2017 | $170,000 | +26.9% | 3,282 | +8.7% | 0.02% | +20.0% |
| Q4 2016 | $134,000 | -19.3% | 3,020 | -13.4% | 0.02% | -28.6% |
| Q3 2016 | $166,000 | -51.0% | 3,487 | -53.5% | 0.02% | -53.3% |
| Q2 2016 | $339,000 | -32.9% | 7,493 | -39.0% | 0.04% | -36.6% |
| Q1 2016 | $505,000 | +2.0% | 12,293 | -5.1% | 0.07% | 0.0% |
| Q4 2015 | $495,000 | +6.5% | 12,960 | -8.4% | 0.07% | -1.4% |
| Q3 2015 | $465,000 | -36.7% | 14,141 | +34.5% | 0.07% | -32.7% |
| Q2 2015 | $735,000 | +71.3% | 10,511 | +67.6% | 0.11% | +72.6% |
| Q1 2015 | $429,000 | -56.9% | 6,273 | -53.8% | 0.06% | -57.2% |
| Q4 2014 | $995,000 | +13.8% | 13,579 | +11.6% | 0.14% | +9.8% |
| Q3 2014 | $874,000 | +10.9% | 12,172 | +11.7% | 0.13% | +8.2% |
| Q2 2014 | $788,000 | +8.8% | 10,898 | +10.7% | 0.12% | +2.5% |
| Q1 2014 | $724,000 | +30.0% | 9,847 | +23.0% | 0.12% | +28.0% |
| Q4 2013 | $557,000 | +85.7% | 8,007 | +75.3% | 0.09% | +69.1% |
| Q3 2013 | $300,000 | +222.6% | 4,568 | +240.9% | 0.06% | +205.6% |
| Q2 2013 | $93,000 | – | 1,340 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |